IQInvest research note
25 AUG 2026 · 15:25 ET
ABT
Abbott Laboratories
$115.28
-$1.39 (-1.19%)down -1.19%
25 August 2026 · delayed 15+ min
F
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
Abbott Laboratories earns a F on good profit margins (>10%) and positive free cash flow but high debt-to-equity ratio (>2.0) and negative earnings growth. Consider alternatives with better risk/reward profiles.
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these
IQ-ABT-20260825engine v1 · 7-category weighted scorecard